on 21 Oct 2023
Last Applicant/ Owned by
PARK innovAARE
Villigen
CH
CH-5234
Serial Number
79189464 filed on 16th Mar 2016
Registration Number
5173690 registered on 04th Apr 2017
Correspondent Address
Dyan M. House
Filing Basis
1. filing basis filed as 66 a
Disclaimer
NO DATA
Scientific and technological research, namely, enablement of structure-based drug design by generation of target protein, molecular structures by X-ray crystallography, electron microscopy, and other methods to generate and design new active pharmaceutical ingredients, namely, chemical entities and biopharmaceuticals, for the treatment of diseases; research and molecular design in the field of medRead More
[ Medical services ]
Scientific and technological research, namely, enablement of structure-based drug design by generation of target protein, molecular structures by X-ray crystallography, electron microscopy, and other methods to generate and design new active pharmaceutical ingredients, namely, chemical entities and biopharmaceuticals, for the treatment of diseases; research and molecular design in the field of medical sciences and pharmaceuticals; industrial analysis and research services in the field of medical sciences and pharmaceuticals
Pharmaceutical preparations for the treatment of infectious diseases, oncologic diseases, and diseases of the central nervous system
No 79189464
No Service Mark
No
No
No
No
No
Yes
Yes
No
No
| Status Date | Action Taken |
|---|---|
| 23rd Feb 2024 | NEW REPRESENTATIVE AT IB RECEIVED |
| 21st Oct 2023 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| 21st Oct 2023 | REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK. |
| 21st Oct 2023 | NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED |
| 28th Mar 2023 | TEAS SECTION 71 & 15 RECEIVED |
| 04th Apr 2022 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED |
| 28th Jul 2017 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| 06th Jul 2017 | FINAL DISPOSITION PROCESSED |
| 06th Jul 2017 | FINAL DISPOSITION NOTICE SENT TO IB |
| 04th Jul 2017 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
